RTI Biologics, a provider of sterile biologic implants for surgeries, has introduced new meniscus allograft instrumentation.
The new instrument is developed through surgeon recommendations by enhancing the design of several critical components of the set for implant procedure.
RTI prepares human donated tissue and bovine tissue for transplantation through testing and screening and using proprietary processes.
The allograft and xenograft implants are used in orthopedic, dental and other specialty surgeries.
RTI offers precision-tooled bone implants and assembled technology to maximize validated sterilization processes that include viral inactivation steps.
The inactivation steps include two processes BioCleanse Tissue Sterilization Process and the Tutoplast Tissue Sterilization Process with zero incidence of allograft-associated infection.
These processes have been validated by tissue type to inactivate or remove viruses, bacteria, fungi and spores from the tissue while maintaining biocompatibility and functionality.